FDA Issues Safety Alert on Liver Disease Drug

(MedPage Today) -- Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safety communication on Thursday.
The agency's review...